1. Home
  2. UAA vs FOLD Comparison

UAA vs FOLD Comparison

Compare UAA & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UAA
  • FOLD
  • Stock Information
  • Founded
  • UAA 1996
  • FOLD 2002
  • Country
  • UAA United States
  • FOLD United States
  • Employees
  • UAA N/A
  • FOLD N/A
  • Industry
  • UAA Apparel
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • UAA Consumer Discretionary
  • FOLD Health Care
  • Exchange
  • UAA Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • UAA 2.5B
  • FOLD 2.9B
  • IPO Year
  • UAA N/A
  • FOLD 2007
  • Fundamental
  • Price
  • UAA $7.03
  • FOLD $5.64
  • Analyst Decision
  • UAA Hold
  • FOLD Buy
  • Analyst Count
  • UAA 18
  • FOLD 10
  • Target Price
  • UAA $7.27
  • FOLD $16.22
  • AVG Volume (30 Days)
  • UAA 10.6M
  • FOLD 4.5M
  • Earning Date
  • UAA 08-07-2025
  • FOLD 08-07-2025
  • Dividend Yield
  • UAA N/A
  • FOLD N/A
  • EPS Growth
  • UAA N/A
  • FOLD N/A
  • EPS
  • UAA N/A
  • FOLD N/A
  • Revenue
  • UAA $5,164,310,000.00
  • FOLD $543,141,000.00
  • Revenue This Year
  • UAA N/A
  • FOLD $19.84
  • Revenue Next Year
  • UAA $2.72
  • FOLD $23.18
  • P/E Ratio
  • UAA N/A
  • FOLD N/A
  • Revenue Growth
  • UAA N/A
  • FOLD 28.25
  • 52 Week Low
  • UAA $4.78
  • FOLD $5.62
  • 52 Week High
  • UAA $11.89
  • FOLD $12.65
  • Technical
  • Relative Strength Index (RSI)
  • UAA 59.47
  • FOLD 33.65
  • Support Level
  • UAA $6.15
  • FOLD $6.00
  • Resistance Level
  • UAA $7.17
  • FOLD $6.22
  • Average True Range (ATR)
  • UAA 0.28
  • FOLD 0.19
  • MACD
  • UAA -0.04
  • FOLD -0.01
  • Stochastic Oscillator
  • UAA 86.27
  • FOLD 2.70

About UAA Under Armour Inc.

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: